Potential roles of insulin and IGF-1 in Alzheimer's disease

被引：224
|
作者：
Gasparini, L
Xu, HX
机构：
[1] Nicox Res Inst, I-20091 Milan, Italy
[2] Rockefeller Univ, Fisher Ctr Res Alzheimer Dis, New York, NY 10021 USA
来源：
TRENDS IN NEUROSCIENCES | 2003年 / 26卷 / 08期
关键词：
D O I：
10.1016/S0166-2236(03)00163-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Aging is characterized by a significant decline of metabolic and hormonal functions, which often facilitates the onset of severe age-associated pathologies. One outstanding example of this is the reported association of deranged signaling by insulin and insulin-like-growth-factor 1 (IGF-1) with Alzheimer's disease (AD). Recent compelling biological data reveal effects of insulin and IGF-1 on molecular and cellular mechanisms underlying the pathology of AD. This review discusses available biological data that highlight the therapeutic potential of the insulin-IGF-1 signaling pathway in AD.
引用
收藏
页码：404 / 406
页数：3
相关论文
共 50 条
  • [1] Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease
    O'Neill, Cora
    Kiely, Aoife P.
    Coakley, Meghan F.
    Manning, Sean
    Long-Smith, Caitriona M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 721 - 727
  • [2] Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
    Giuffrida, Maria Laura
    Tomasello, Flora
    Caraci, Filippo
    Chiechio, Santina
    Nicoletti, Ferdinando
    Copani, Agata
    MOLECULAR NEUROBIOLOGY, 2012, 46 (03) : 605 - 613
  • [3] Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
    Maria Laura Giuffrida
    Flora Tomasello
    Filippo Caraci
    Santina Chiechio
    Ferdinando Nicoletti
    Agata Copani
    Molecular Neurobiology, 2012, 46 : 605 - 613
  • [4] Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
    Moloney, Aileen M.
    Griffin, Rebecca J.
    Timmons, Suzanne
    O'Connor, Rosemary
    Ravid, Rivka
    O'Neill, Cora
    NEUROBIOLOGY OF AGING, 2010, 31 (02) : 224 - 243
  • [5] Abnormalities in insulin, IGF-1, and corresponding receptor (R) expression in Alzheimer's disease.
    Terry, BM
    Cannon, JC
    Guong, L
    Wands, JR
    de la Monte, SM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 546 - 546
  • [6] Severity of dementia in Alzheimer's disease depends on IGF-1 level but not on IGF-1 promoter polymorphism
    Geppert, A. M.
    Koczorowska, M.
    Gozdzicka-Jozefiak, A.
    Przedpelska-Ober, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 181 - 181
  • [7] Insulin-Like Growth Factor 1 (IGF-1) and Risk of Alzheimer's Disease: The Framingham Study
    Westwood, Andrew J.
    Baiser, Alexa S.
    Vasan, Ramachandran S.
    Harris, Tamara B.
    Roubenoff, Ronenn
    Pikula, Aleksandra
    Au, Rhoda
    DeCarli, Charles
    Wolf, Philip A.
    Seshadri, Sudha
    ANNALS OF NEUROLOGY, 2011, 70 : S51 - S51
  • [8] The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimer's Disease: From Model Organisms to Human Disease
    Freude, S.
    Schilbach, K.
    Schubert, M.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 213 - 223
  • [9] Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer's disease
    Ala, Tom
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (01) : 108 - 112
  • [10] Insulin, IGF-1 and longevity
    van Heemst, Diana
    AGING AND DISEASE, 2010, 1 (02): : 147 - 157
12345